🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This phase II trial tests whether treosulfan, fludarabine, and rabbit antit...
Status
Completed
Location
Children's Hospital Los Angeles
Start Date
2022-04-19
Trial ID
NCT04965597
Treatments Being Tested
This phase II trial studies how well vedolizumab plus post-transplant cyclo...
Status
Recruiting
Location
City of Hope Medical Center
Start Date
2025-04-18
Trial ID
NCT06815003
The purpose of this study is to investigate the sensitivity and accuracy of...
Status
Completed
Location
New York Presbyterian Hospital/Columbia University Irving Medical Center
Start Date
2022-09-14
Trial ID
NCT05625971
Treatments Being Tested
The investigators aimed to study the effect of chemotherapy on regulatory T...
Status
Unknown
Location
Multiple Locations
Start Date
2018-01
Trial ID
NCT03413046
Treatments Being Tested
Background: B-cell leukemias and lymphomas are cancers that are often diff...
Status
Completed
Location
National Institutes of Health Clinical Center
Start Date
2018-03-26
Trial ID
NCT03448393
This study is a clinical study aiming at establishing immunological assays ...
Status
Completed
Location
Peter MacCallum Cancer Center
Start Date
2013-10
Trial ID
NCT02016833
Treatments Being Tested
In this study, the investigators seek to determine whether decitabine thera...
Status
Terminated
Location
Washington University School of Medicine
Start Date
2017-07-14
Trial ID
NCT03063203
Treatments Being Tested
The purpose of this phase I study is to test the safety of different dose l...
Status
Active Not Recruiting
Location
Memorial Sloan Kettering Cancer Center
Start Date
2017-03-15
Trial ID
NCT03085173
Treatments Being Tested
This phase I/II trial studies the side effects and best dose of pralatrexat...
Status
Recruiting
Location
Fred Hutch/University of Washington Cancer Consortium
Start Date
2026-04-27
Trial ID
NCT07225985
Treatments Being Tested
This phase I/II trial studies the side effects and best dose of a radioacti...
Status
Recruiting
Location
Fred Hutch/University of Washington Cancer Consortium
Start Date
2019-07-10
Trial ID
NCT03670966
Treatments Being Tested